JPMorgan Downgrades Mereo BipPharma Group (MREO) to Underweight
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.37 +8.82%
Rating Summary:
3 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
3 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
JPMorgan analyst Priyanka Grover downgraded Mereo BipPharma Group (NASDAQ: MREO) from Neutral to Underweight.
For an analyst ratings summary and ratings history on Mereo BipPharma Group click here. For more ratings news on Mereo BipPharma Group click here.
Shares of Mereo BipPharma Group closed at $0.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Pool Corporation names former Constellium CEO to its board
- Tempest Therapeutics (TPST) files for 9.53M share offering by selling stockholders
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorgan, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
